Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Daxor Corporation - Closed End Fund (NQ:DXR)

11.03 -0.35 (-3.08%)
Streaming Delayed Price Updated: 3:49 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,658
Open 11.28
Bid (Size) 7.000 (1)
Ask (Size) 11.22 (2)
Prev. Close 11.38
Today's Range 10.26 - 11.28
52wk Range 6.550 - 11.38
Shares Outstanding 4,196,182
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Gainers SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss. 
Via Benzinga

Performance

YTD
+46.1%
+46.1%
1 Month
+18.2%
+18.2%
3 Month
+53.2%
+53.2%
6 Month
+52.8%
+52.8%
1 Year
+22.6%
+22.6%

More News

Read More
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
From Daxor Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected
Via Benzinga
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
From Daxor Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
From Daxor Corporation
Via GlobeNewswire
Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs
From Daxor Corporation
Via GlobeNewswire
Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
From Daxor Corporation
Via GlobeNewswire
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
From Daxor Corporation
Via GlobeNewswire
Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting
From Daxor Corporation
Via GlobeNewswire
DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
From Daxor Corporation
Via GlobeNewswire
Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting
From Daxor Corporation
Via GlobeNewswire
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
From Daxor Corporation
Via GlobeNewswire
New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
From Daxor Corporation
Via GlobeNewswire
New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
From Daxor Corporation
Via GlobeNewswire
Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
From Daxor Corporation
Via GlobeNewswire
32 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
From MicroCap Rodeo
Via AccessWire
64 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga

Frequently Asked Questions

Is Daxor Corporation - Closed End Fund publicly traded?
Yes, Daxor Corporation - Closed End Fund is publicly traded.
What exchange does Daxor Corporation - Closed End Fund trade on?
Daxor Corporation - Closed End Fund trades on the Nasdaq Stock Market
What is the ticker symbol for Daxor Corporation - Closed End Fund?
The ticker symbol for Daxor Corporation - Closed End Fund is DXR on the Nasdaq Stock Market
What is the current price of Daxor Corporation - Closed End Fund?
The current price of Daxor Corporation - Closed End Fund is 11.03
When was Daxor Corporation - Closed End Fund last traded?
The last trade of Daxor Corporation - Closed End Fund was at 08/13/25 03:49 PM ET
What is the market capitalization of Daxor Corporation - Closed End Fund?
The market capitalization of Daxor Corporation - Closed End Fund is 46.28M
How many shares of Daxor Corporation - Closed End Fund are outstanding?
Daxor Corporation - Closed End Fund has 46M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.